Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen A M Schenk-Braat

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Urology|May 12, 2007
Re: Five-year follow-up of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancerEllen A M Schenk-Braat
Cancer Immunology, Immunotherapy : CII|November 27, 2004
Immunotherapy for superficial bladder cancerEllen A M Schenk-Braat, Chris H Bangma
The Journal of Gene Medicine|August 28, 2007
Gene therapy in The Netherlands: highlights from the Low CountriesEllen A M Schenk-Braat, Leonie C M Kaptein, Marcella M Hallemeesch, et al.
The Journal of Gene Medicine|September 21, 2007
An inventory of shedding data from clinical gene therapy trialsEllen A M Schenk-Braat, Marjolein M K B van Mierlo, Gerard Wagemaker, et al.
The Prostate|January 18, 2014
Serum levels of arachidonic acid metabolites change during prostate cancer progressionGiovanny Rodríguez-Blanco, Peter C Burgers, Lennard J M Dekker, et al.
Clinical Biochemistry|May 17, 2014
Serum kynurenine/tryptophan ratio is not a potential marker for detecting prostate cancerGiovanny Rodríguez-Blanco, Peter C Burgers, Lennard J M Dekker, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Urology|May 12, 2007
Re: Five-year follow-up of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancerEllen A M Schenk-Braat
Cancer Immunology, Immunotherapy : CII|November 27, 2004
Immunotherapy for superficial bladder cancerEllen A M Schenk-Braat, Chris H Bangma
The Journal of Gene Medicine|August 28, 2007
Gene therapy in The Netherlands: highlights from the Low CountriesEllen A M Schenk-Braat, Leonie C M Kaptein, Marcella M Hallemeesch, et al.
The Journal of Gene Medicine|September 21, 2007
An inventory of shedding data from clinical gene therapy trialsEllen A M Schenk-Braat, Marjolein M K B van Mierlo, Gerard Wagemaker, et al.
The Prostate|January 18, 2014
Serum levels of arachidonic acid metabolites change during prostate cancer progressionGiovanny Rodríguez-Blanco, Peter C Burgers, Lennard J M Dekker, et al.
Clinical Biochemistry|May 17, 2014
Serum kynurenine/tryptophan ratio is not a potential marker for detecting prostate cancerGiovanny Rodríguez-Blanco, Peter C Burgers, Lennard J M Dekker, et al.
Pageof 1